Acrokeratoelastoidosis of CostaSymptoms, Doctors, Treatments, Advances & More
Acrokeratoelastoidosis of Costa Overview
Learn About Acrokeratoelastoidosis of Costa
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Toshifumi Nomura practices practicing medicine in Tsukuba, Japan. Nomura is rated as an Elite expert by MediFind in the treatment of Acrokeratoelastoidosis of Costa. They are also highly rated in 24 other conditions, according to our data. Their clinical expertise encompasses Palmoplantar Keratoderma, Acrokeratoelastoidosis of Costa, Epidermolytic Hyperkeratosis, and Ichthyosis Vulgaris.
Alain Hovnanian practices practicing medicine in Paris, France. Mr. Hovnanian is rated as an Elite expert by MediFind in the treatment of Acrokeratoelastoidosis of Costa. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Netherton Syndrome, Olmsted Syndrome, Dystrophic Epidermolysis Bullosa, and Epidermolysis Bullosa.
Toshinari Miyauchi practices practicing medicine in Sapporo, Japan. Miyauchi is rated as an Elite expert by MediFind in the treatment of Acrokeratoelastoidosis of Costa. They are also highly rated in 9 other conditions, according to our data. Their clinical expertise encompasses Acrokeratoelastoidosis of Costa, Palmoplantar Keratoderma, Epidermolytic Hyperkeratosis, and Nonbullous Congenital Ichthyosiform Erythroderma.
Summary: The purpose of this study is to assess adults with palmoplantar keratoderma (thickening skin layer on palms and soles) who are treated with the study drug, tapinarof. This is a naturally occuring compound used for the treatment of psoriasis. This study is being done to find out how well and safe this drug is for stopping or treating keratoderma. This study aims to investigate the positive impacts ...
Summary: The goal of this observational study is to conduct a prospective assessment of the individual Burden of 9 rare skin diseases to assess disability in the broadest sense of the term (psychological, social, economic and physical) for patients and/or families. Two types of indicators will be used to reach this objective : 1. an individual burden score calculated based on a burden questionnaire created...